SC Fiterman Pharma SRL   Report issue

For profit Phase 4
Founded: Iasi Romania (1994)
Status: No NME R&D (1994)

Organization Overview

First Clinical Trial
2016
NCT02669641
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Fiterman Pharma SRL

Active Ingredients

Drugs in Phase 4 Trials (3)

choline c11 (choline c-11) (2 trials)

phyllanthus (1 trial)

silymarin (2 trials)

Drugs in Other Trials (1)

inulin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatty Liver (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4